Immunohistochemical analysis of noncancerous pulmonary tissue and tumor tissues from NSCLC patients revealed that ILK was highly expressed in 31% of NSCLC tissues, while it was not detected in normal tissues. This evidence concerns the gene ILK and non-small cell lung carcinoma.